SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3432Maybe than it is unknown future for COV2-Abs!? REGN predicted (and demonstrated Miljenko Zuanic-2/4/2022
3431Roche COV2 546 chf for q4 - I don’t think regeneron get much as Roche is supplyBioBait-2/3/2022
3430FDA approves Vabysmo—Roche’s bispecific mAb—for_wet AMD/DME: businesswire.com DewDiligence_on_SI-1/28/2022
3429Yes, too many of the participants probably had multiple allergic conditions. NoBioBait-1/14/2022
3428Mentioned by George at end of JPM Q&A. He all but said it didn't work wCuttingEdge Bio-1/13/2022
3427Betv1 Updated patent. Maybe we’ll find out soon if trial worked.BioBait-1/6/2022
3426All 4 mabs being distributed BioBait-1/3/2022
3425Yup, REGN is optimistic about, they took 50-50 option.Miljenko Zuanic-12/30/2021
3424Aln-app partnership news - Company Expects to Initiate a Phase 1 Study in EarlBioBait-12/22/2021
3423Here's your answer: endpts.comFelix B-12/16/2021
3422Now we wait to see how long it takes omicron to become dominant. Not long. I A.J. Mullen-12/16/2021
3421Regeneron says its coronavirus antibody cocktail loses potency against omicron BioBait-12/16/2021
3420I meant Cell paper, not Science. cell.comCuttingEdge Bio-12/13/2021
3419Not MERS but SARS. A shared epitope on the SARS spike that is highly conserved CuttingEdge Bio-12/13/2021
3418Still not distributing vir.BioBait-12/13/2021
3417<It does seem that VIR chose a very good epitope to target.> From start thMiljenko Zuanic-12/13/2021
3416Sorry I read this wrong initially. You didn't propose to stop distributing CuttingEdge Bio-12/8/2021
3415There are too many Delta cases still in the US to stop using it. And VIR/GSK dCuttingEdge Bio112/8/2021
3414That is interesting idea. I wish the website showed total distribution as opposFelix B-12/8/2021
3413phe.gov Wonder if they stopped distributing to save it for omicron? Or just ruBioBait-12/7/2021
3412VIR has only 3-fold decline in neutralization with pseudotyped omicron in cell cCuttingEdge Bio-12/7/2021
3411H.C. Wainwright & Co. – Unlocking the Full Potential of RNAi With World-ClasBioBait-12/6/2021
3410Botulinum toxin may work in AMD: twitter.comDewDiligence_on_SI-11/30/2021
3409Will regen-cov be ineffective against omicron and will omicron become dominant iBioBait-11/29/2021
3408But if Omicron spreads, will next contract have to wait for a new cocktail to geCuttingEdge Bio-11/29/2021
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News